91 | Immunotherapy rechallenge in NSCLC 2022-03-03 |
Play |
92 | ESO’s career development programme 2022-02-24 |
Play |
93 | Summary/Review - Reporting Guidelines - CONSORT 2022-02-17 |
Play |
94 | Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0 2022-02-10 |
Play |
95 | Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease. 2022-02-03 |
Play |
96 | Intraoperative breast ultrasound 2022-01-27 |
Play |
97 | Summary/Review - Reporting Guidelines - PRISMA 2020 2022-01-20 |
Play |
98 | Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism. 2022-01-13 |
Play |
99 | Advanced Gastric Cancer 2021-12-09 |
Play |
100 | PARP inhibitors for the treatment of ovarian cancer 2021-12-02 |
Play |